Qiagen N.V. reported $2.09B of revenue over the trailing twelve months, +5.7% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.09B (to FY2025). Net Income: $425M, trailing twelve months to FY2025. Free Cash Flow: $453M, trailing twelve months to FY2025. Op Margin: 22%, trailing twelve months to FY2025.

QGENQiagen N.V.

HealthcareUSD

$42.39

$32.6352 weeks$55.66

Latest close: below its 200-day averageSep 8, 2026what changed →

QGEN as reported

Qiagen N.V. reported $2.09B of revenue over the trailing twelve months, +5.7% on the year before. 11 reported series are charted on this page, each one as filed.

$2.09B

Revenue, trailing twelve months · to FY2025 · +5.7% against the twelve months before

Net Income: $425M
Net Income · +408% year on year · trailing twelve months to FY2025
Free Cash Flow: $453M
Free Cash Flow · −10% year on year · trailing twelve months to FY2025
Op Margin: 22%
Op Margin · trailing twelve months to FY2025

Every series Ryufin has for QGEN, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.09B	+5.7%	FY2025
Net Income	$425M	+408%	FY2025
EPS	$1.94	+424%	FY2025
Gross Margin	62%	n/a	FY2025
Op Margin	22%	n/a	FY2025
Net Margin	20%	n/a	FY2025
ROE	11%	n/a	FY2025
ROA	6.8%	n/a	FY2025
ROIC	8.5%	n/a	FY2025
Free Cash Flow	$453M	−10%	FY2025
P/E	21.9	n/a	today